Insilico Medicine Announced Earlier, AI Drug Discovery Collaboration With Takeda Worth Up To $600M; Insilico To Receive~$60M In Initiation Fees, Near-Term Payments, Milestones, Eligible For Additional Preclinical, Clinical, Commercial, Sales Milestones Plus Tiered Royalties On Future Sales